InvestorNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Announces Agreement with CROSSMARK, Could Include 100,000+ Points of Sale

February 3, 2021 09:38:34
TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRA: 2TP2), a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco, has announced that its flagship product will be represented by CROSSMARK Inc. CROSSMARK is a Texas-based sales and marketing agency with more than 25,000 employees and proven success in commercializing tobacco alternatives. The company will be representing all three varieties of TAAT and will be intent on securing on-shelf retail availability at more than 100,000 convenience stores located throughout the United States. The agreement notes that, in addition to providing sales support for TAAT, CROSSMARK will focus on merchandising as well as strengthening and building in-store acceptance of TAAT’s tobacco-free and nicotine-free alternative to traditional cigarettes. “Ever since TAAT was first placed on store shelves in Ohio in December 2020, we have received glowing feedback about the product from both legal-aged smokers and retailers alike,” said TAAT CEO Seth Coscarella in the press release. “It is common knowledge in the world of business that this is only the first step towards the success of a product launch. We selected CROSSMARK to represent TAAT because their formula for creating, implementing, and executing strategies for CPG merchandising has been honed over decades of bringing new consumer products to mainstream retail channels. In addition to leveraging their relationships with major retailers and wholesalers across our targeted channels for TAAT, CROSSMARK also offers an impressive suite of ‘back office’ functions including marketing, data analytics, and order processing support. Altogether, these services could enable TAAT to penetrate the tobacco market much more rapidly and efficiently compared to building out our own national sales and merchandising team from scratch.” To view the full press release, visit https://ibn.fm/VVpJ2 About TAAT Lifestyle & Wellness Ltd. TATT has developed its namesake TAAT product, a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020. TATT is seeking to position itself in the $814-billion global tobacco industry. For more information, please visit www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.